AbbVie Inc. (ABBV)
After hours:
| Previous close | 162.73 |
| Open | 164.41 |
| Bid | 162.41 x 1200 |
| Ask | 163.30 x 1000 |
| Day's range | 161.89 - 163.99 |
| 52-week range | 130.96 - 182.89 |
| Volume | |
| Avg. volume | 5,695,118 |
| Market cap | 287.042B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 48.52 |
| EPS (TTM) | 3.35 |
| Earnings date | 25 July 2024 - 29 July 2024 |
| Forward dividend & yield | 6.20 (3.81%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | 183.20 |
Barrons.comTeva Earnings Are Soon. What Could Keep the Stock Gains Going.
Shares of Teva Pharmaceutical Industries have done something unusual this year: They’ve gone up. The company’s American depositary receipt, which spent much of the past decade falling in value or stagnating at rock-bottom levels, has shot up nearly 35% this year. On Wednesday morning, executives will present the Teva’s first-quarter results, and face questions from Wall Street about whether the company can sustain this upswing.
Insider Monkey15 Best S&P 500 Dividend Stocks To Buy Now
In this article, we discuss 15 best S&P 500 dividend stocks to buy now. You can skip our detailed analysis of dividend stocks in the S&P 500 and their past performance, and go directly to read 5 Best S&P 500 Dividend Stocks To Buy Now. It’s been a dynamic first quarter for the stock market. […]
Zacks3 Top Dividend Stocks to Maximize Your Retirement Income
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
